#1: ジャーナル: J.Mol.Biol. / 年: 1989 タイトル: Crystallization and Preliminary X-Ray Diffraction Studies of an Anti-4-Hydroxy-3-Nitrophenylacetic Acid Monoclonal Antibody Fab Fragment Complexed with Immunizing and Heteroclitic Haptens 著者: Yuhasz, S.C. / Ysern, X. / Strand, M. / Amzel, L.M.
履歴
登録
1996年1月30日
処理サイト: BNL
改定 1.0
1996年7月11日
Provider: repository / タイプ: Initial release
改定 1.1
2008年3月24日
Group: Version format compliance
改定 1.2
2011年7月13日
Group: Version format compliance
改定 1.3
2013年9月18日
Group: Source and taxonomy
改定 1.4
2018年3月21日
Group: Data collection / Other / カテゴリ: diffrn_detector / pdbx_database_status Item: _diffrn_detector.pdbx_collection_date / _pdbx_database_status.process_site
IN THE NUMBERING SCHEME USED IN THIS ENTRY, THE LIGHT CHAIN RESIDUES FOR MOLECULE 1 ARE VL1 2 - ...IN THE NUMBERING SCHEME USED IN THIS ENTRY, THE LIGHT CHAIN RESIDUES FOR MOLECULE 1 ARE VL1 2 - 109, CL1 110 - 212 AND THE HEAVY CHAIN RESIDUES ARE VH1 1 - 117, CH1 118 - 218, RESPECTIVELY. MOLECULE 2 DEFINES THE LIGHT CHAIN RESIDUES AS VL2 2 - 109, CL2 110 - 212, AND HEAVY CHAIN RESIDUES AS VH2 1 - 117 AND CH2 118 - 218, RESPECTIVELY. THE WATERS ARE NUMBERED 990 - 994 AND THE 2 NITROPHENOL-EPSILON-AMINO CAPROIC MOLECULES LABELED AS NP ARE NUMBERED 995 AND 996.
解像度: 3→6 Å / σ(F): 2 詳細: IN THE NUMBERING SCHEME USED IN THIS ENTRY, THE LIGHT CHAIN RESIDUES FOR MOLECULE 1 ARE VL1 2 - 109, CL1 110 - 212 AND THE HEAVY CHAIN RESIDUES ARE VH1 1 - 117, CH1 118 - 218, RESPECTIVELY. ...詳細: IN THE NUMBERING SCHEME USED IN THIS ENTRY, THE LIGHT CHAIN RESIDUES FOR MOLECULE 1 ARE VL1 2 - 109, CL1 110 - 212 AND THE HEAVY CHAIN RESIDUES ARE VH1 1 - 117, CH1 118 - 218, RESPECTIVELY. MOLECULE 2 DEFINES THE LIGHT CHAIN RESIDUES AS VL2 2 - 109, CL2 110 - 212, AND HEAVY CHAIN RESIDUES AS VH2 1 - 117 AND CH2 118 - 218, RESPECTIVELY. THE WATERS ARE NUMBERED 990 - 994 AND THE 2 NITROPHENOL-EPSILON-AMINO CAPROIC MOLECULES LABELED AS NP ARE NUMBERED 995 AND 996. RESIDUES NUMBERED 132 - 140 OF H AND B CHAINS WERE NOT FOUND IN THE ELECTRON DENSITY AND ARE PROBABLY DISORDERED.